KOL | Inger Jorid BergDepartment of Rheumatology, Diakonhjemmet Hospital | Department of Rheumatology, Oslo, Norway | Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway | ... |
KOL Resume for Inger Jorid Berg
| Year | |
|---|---|
| 2020 | Department of Rheumatology, Diakonhjemmet Hospital |
| 2019 | Department of Rheumatology, Oslo, Norway |
| 2018 | From the Department of Heart Disease and Department of Rheumatology, Haukeland University Hospital; Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen; Department of Rheumatology, Diakonhjemmet Hospital; Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. H. Midtbø, Postdoctor, MD, PhD, Department of Heart Disease, Haukeland University Hospital; E. Gerdts, Professor, MD, PhD, Department of Clinical Science, University of Bergen; I.J. Berg, Consultant Rheumatologist, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; S. Rollefstad, Postdoctor, MD, PhD, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital; R. Jonsson, Professor, DMD, PhD, Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, and Department of Rheumatology, Haukeland University Hospital; A.G. Semb, Consultant Cardiologist, Senior Researcher, MD, PhD, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital. |
| 2016 | From the Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital; Section of Vascular Investigations, Oslo University Hospital Aker; National Resource Centre for Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital, Oslo; Martina Hansens Hospital, Bærum; Division of Rheumatology, Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway.E. Ikdahl, MD, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital; S. Rollefstad, MD, PhD, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital; G. Wibetoe, MD, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital; I.C. Olsen, PhD, Department of Rheumatology, Diakonhjemmet Hospital; I.J. Berg, MD, Department of Rheumatology, Diakonhjemmet Hospital; J. Hisdal, DrPhilos, Section of Vascular Investigations, Oslo University Hospital Aker; T. Uhlig, MD, Professor, National Resource Centre for Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital; G. Haugeberg, MD, Professor, Martina Hansens Hospital, and Division of Rheumatology, Department of Neuroscience, Norwegian University of Science and Technology; T.K. Kvien, MD, Professor, Department of Rheumatology, Diakonhjemmet Hospital; S.A. Provan, MD, PhD, Department of Rheumatology, Diakonhjemmet Hospital; A.G. Semb, MD, PhD, Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital. |
| 2015 | Rheumatology, Diakonhjemmet Hospital, Oslo, Norway |
| 2014 | Department of Rheumatology, Diakonhjemmet Hospital, Box 23 Vinderen, Oslo N-0319, Norway |
Inger Jorid Berg: Influence Statistics
| Concept | World rank |
|---|---|
| emotional distress ability | #4 |
| worst ability | #4 |
| asdas p0001 | #5 |
| axspa patients function | #5 |
| outcome asdas | #5 |
| 100 patients exercise | #5 |
| training spondylarthritis | #5 |
| diabetes serum crp | #5 |
| therapy fatigue asdas | #5 |
| primary outcome asdas | #5 |
| lv hypertrophy independent | #5 |
| axspa multicentre | #5 |
| axspa method | #6 |
| range poor quality | #6 |
| 100 patients axspa | #6 |
| vitality 50 95 | #6 |
| control intensity exercise | #6 |
| exercises emotional | #6 |
| severe vitality | #6 |
| highintensity exercises fatigue | #6 |
| mood general health | #7 |
| 106 patients ± | #8 |
| 118 participating patients | #8 |
| crosssectional associations vo2peak | #8 |
| conclusion reduced crf | #8 |
| lower gls controls | #8 |
| nrs ability | #8 |
| basdai p0001 | #8 |
| vo2peak cardiovascular disease | #8 |
| 12 years 59 | #8 |
| patients lower gls | #8 |
| gls larger | #9 |
| ankylosing vascular stiffness | #9 |
| axspa intervention | #9 |
| gls cvd | #9 |
| axspa exercise | #10 |
| spondyloarthritis secondary | #10 |
| vitality 50 | #10 |
| 50 95 95 | #11 |
| asdas secondary | #11 |
| 97 randomised | #11 |
| 21 worst | #11 |
| methods vo2peak | #11 |
| vo2peak arterial stiffness | #12 |
| average 49 ± | #13 |
| ± 177 ± | #13 |
| axspa sacroiliitis | #15 |
| vo2peak arterial | #15 |
| 2 spa features | #15 |
| stiffness ankylosing | #15 |
Open the FULL List in Excel | |
Prominent publications by Inger Jorid Berg
OBJECTIVE: To compare magnetic resonance images (MRIs) of the sacroiliac (SI) joints of healthy subjects and individuals with known mechanical strain acting upon the SI joints to those of patients with axial spondyloarthritis (SpA) and patients with chronic back pain.
METHODS: Three readers who had received standardized training and were blinded with regard to study group randomly scored MRIs of the SI joints of 172 subjects, including 47 healthy individuals without current or past back ...
| Known for Sacroiliac Joints | Healthy Individuals | Chronic Pain | Magnetic Resonance | Patients Axial Spondyloarthritis |
BackgroundThe Assessment of SpondyloArthritis international Society (ASAS) definition of a positive family history (PFH) of spondyloarthritis (SpA) includes the following diseases in first- or second-degree relatives: ankylosing spondylitis (AS), acute anterior uveitis (AAU), reactive arthritis (ReA), inflammatory bowel disease (IBD), and psoriasis. However, it is not known if a PFH for each of these diseases contributes to making a diagnosis of axSpA, sacroiliitis on imaging, or ...
| Known for Axial Spondyloarthritis | Pfh Aau | Axspa Diagnosis | Hla B27 | Rea Ibd |
OBJECTIVE: To identify factors associated with elevated arterial stiffness in a 5-year follow-up of patients with ankylosing spondylitis (AS).
METHODS: C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), Bath AS disease activity index (BASDAI) and AS disease activity score (ASDAS) were recorded in 2003, and arterial stiffness (Augmentation Index (AIx) and pulse wave velocity (PWV)) in 2008/2009. Patients were grouped into quartiles according to baseline CRP, ESR and BASDAI ...
| Known for Ankylosing Spondylitis | Cardiovascular Disease | Arterial Stiffness | Crp Esr | Basdai Asdas |
OBJECTIVES: Concerns have been raised about overdiagnosis of axial spondyloarthritis (axSpA). We investigated whether patients with chronic back pain (CBP) of short duration and multiple SpA features are always diagnosed with axSpA by the rheumatologist, and to what extent fulfilment of the Assessment of SpondyloArthritis International Society (ASAS) axSpA criteria is associated with an axSpA diagnosis.
METHODS: Baseline data from 500 patients from the SPondyloArthritis Caught Early ...
| Known for Axial Spondyloarthritis | Diagnosis Axspa | Patients Cbp | Sacroiliac Joints | Chronic Pain |
BACKGROUND: Exercise is considered important in the management of patients with rheumatic diseases, but the effect of high intensity exercises on disease activity is unknown.
OBJECTIVE: To investigate the effectiveness of high intensity exercises on disease activity in patients with axial spondyloarthritis (axSpA).
METHOD: Assessor blinded multicentre randomised controlled trial. 100 patients (aged from their 20s to their 60s) with axSpA were randomly assigned to an exercise group or to ...
| Known for Intensity Exercise | 3 Months | Patients Axspa | Physical Function | Axial Spondyloarthritis |
OBJECTIVE: We evaluated the predictive value of these vascular biomarkers for cardiovascular disease (CVD) events in patients with rheumatoid arthritis (RA): aortic pulse wave velocity (aPWV), augmentation index (AIx), carotid intima-media thickness (cIMT), and carotid plaques (CP). They are often used as risk markers for CVD.
METHODS: In 2007, 138 patients with RA underwent clinical examination, laboratory tests, blood pressure testing, and vascular biomarker measurements. Occurrence of ...
| Known for Rheumatoid Arthritis | Cardiovascular Disease | Arterial Stiffness | Carotid Atherosclerosis | Patients Cvd |
OBJECTIVES: To assess whether treatment with one of three novel biological DMARDs; rituximab, abatacept or tocilizumab reduce cardiovascular disease (CVD) risk factors in patients with rheumatoid arthritis (RA).
METHODS: This is an open, observational and prospective study with visits at baseline, 3, 6, and 12 months. Patients were assigned to receive rituximab, abatacept or tocilizumab according to clinical indications assessed by an independent rheumatologist. Disease activity was ...
| Known for Cardiovascular Risk | Arthritis Patients | 12 Months | Disease Cvd | Rituximab Abatacept |
OBJECTIVE: To compare the risk of cardiovascular disease (CVD) in ankylosing spondylitis (AS) and population controls, and to examine the associations between disease activity and CVD risk.
METHODS: A cross-sectional study was done of patients with AS grouped according to Ankylosing Spondylitis Disease Activity Score (ASDAS) into ASDAS-high and ASDAS-low. Markers of vascular pathology, impaired endothelial function [asymmetric dimethylarginine (ADMA)], and arterial stiffness ...
| Known for Ankylosing Spondylitis | Cardiovascular Disease | Cvd Risk | Crosssectional Study | Compared Controls |
OBJECTIVES: Insight into the most important inflammatory pathways in ankylosing spondylitis (AS) could be of importance in risk stratification and the development of treatment strategies. Therefore, we aimed to compare circulating levels of inflammatory biomarkers between AS patients and controls, and explore associations between these biomarkers and clinical measures of disease activity.
METHOD: In a cross-sectional study, 143 AS patients were compared with 124 population controls. ...
| Known for Cytokine Receptors | Ankylosing Spondylitis | Circulating Levels | Tumor Necrosis Factor | Opg Patients |
BackgroundAnti-CD74 IgG antibodies are reported to be elevated in patients with axial spondyloarthritis (axSpA). This study assessed the diagnostic value of anti-CD74 antibodies in patients with early axSpA.MethodsAnti-CD74 IgG and IgA antibodies were first measured in an exploratory cohort of patients with radiographic axSpA (138 patients with ankylosing spondyloarthritis (AS)) and 57 healthy controls and then were measured in patients with early axSpA (n = 274) and with non-SpA chronic ...
| Known for Cd74 Antibodies | Patients Early Axspa | Early Axial | Igg Iga | Diagnostic Anti |
BACKGROUND: Physical therapy is recommended for the management of axial spondyloarthritis (axSpA) and flexibility exercises have traditionally been the main focus. Cardiovascular (CV) diseases are considered as a major health concern in axSpA and there is strong evidence that endurance and strength exercise protects against CV diseases. Therefore, the aim of this study was to investigate the efficacy of high intensity endurance and strength exercise on disease activity and CV health in ...
| Known for Intensity Exercise | Axial Spondyloarthritis | Arterial Stiffness | Randomized Controlled | Cardiovascular Risk |
Uveitis is associated with hypertension and atherosclerosis in patients with ankylosing spondylitis: A cross-sectional study
[ PUBLICATION ]
OBJECTIVES: Uveitis is the most common extra-articular manifestation in patients with ankylosing spondylitis (AS), but the literature describing AS patients with a history of uveitis is limited. The objective was to examine if a history of uveitis in patients with AS is associated with increased disease activity and functional impairment and to investigate whether uveitis is associated with an increased frequency of cardiovascular comorbidities, defined here as hypertension and ...
| Known for Ankylosing Spondylitis | Uveitis Patients | Cardiovascular Disease | Multivariate Analysis | Common Extra |
Is a positive family history of spondyloarthritis relevant for diagnosing axial spondyloarthritis once HLA-B27 status is known?
[ PUBLICATION ]
OBJECTIVES: A positive family history (PFH) of spondyloarthritis, in particular a PFH of AS or acute anterior uveitis, is associated with HLA-B27 carriership in chronic back pain patients. As it is unknown, the study aimed to investigate if a PFH contributes to diagnosing axial spondyloarthritis (axSpA) once HLA-B27 status is known.
METHODS: In axSpA-suspected patients from the Assessment of SpondyloArthritis international Society (ASAS), DEvenir des Spondyloarthropathies Indifférenciéés ...
| Known for Axial Spondyloarthritis | Hla B27 | Male Medical | Ankylosing Uveitis | Diagnosis Axspa |
OBJECTIVE: To investigate the value of repeated magnetic resonance imaging (MRI) of the sacroiliac (SI) joints in diagnosing chronic back pain patients in whom axial spondyloarthritis (SpA) is suspected and to examine determinants of positive MRI findings in SI joints.
METHODS: Patients with chronic back pain (duration 3 months-2 years, age ≥16 years, age at onset <45 years) with ≥1 SpA feature who were included in the Spondyloarthritis Caught Early cohort underwent visits at baseline, ...
| Known for Axial Spondyloarthritis | Sacroiliac Joints | 3 Months | Resonance Imaging | Chronic Pain |
INTRODUCTION: Decreasing the diagnostic delay in axial spondyloarthritis (axSpA) remains a major challenge. Here, we assessed the value of serum inflammatory biomarkers to distinguish early axSpA from other pathologies in a large cohort of patients referred with early back pain.
METHODS: Serum c reactive protein (CRP), erythrocyte sedimentation rate (ESR) and calprotectin were determined in the SPondyloArthritis Caught Early (SPACE) cohort (n=310), an early back pain inception cohort. ...
| Known for Axial Spondyloarthritis | Ankylosing Spondylitis | Serum Biomarkers | Reactive Protein | Diagnostic Delay |
Key People For Ankylosing Spondylitis
Inger Jorid Berg:Expert Impact
Concepts for whichInger Jorid Berghas direct influence:Ankylosing spondylitis, Axial spondyloarthritis, Patients axspa, Intensity exercise, Arterial stiffness, Sacroiliac joints, Patients ankylosing spondylitis, Axial spondyloarthritis axspa.
Inger Jorid Berg:KOL impact
Concepts related to the work of other authors for whichfor which Inger Jorid Berg has influence:Axial spondyloarthritis, Ankylosing spondylitis, Rheumatoid arthritis, Arterial stiffness, Physical activity, Sacroiliac joints, Cardiovascular risk.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |